-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UGQcalmhllT8489qYxX1JYHe7UhSV1TKj+t5xT+u00W2fiudVCoYy4Hnb57Viwur lDrs5i5/do4Kzxccyd9VuA== 0001293301-09-000013.txt : 20090811 0001293301-09-000013.hdr.sgml : 20090811 20090811115621 ACCESSION NUMBER: 0001293301-09-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090810 FILED AS OF DATE: 20090811 DATE AS OF CHANGE: 20090811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SALANS LESTER B CENTRAL INDEX KEY: 0001224337 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-05438 FILM NUMBER: 091002678 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FOREST LABORATORIES INC CENTRAL INDEX KEY: 0000038074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 111798614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1202 BUSINESS ADDRESS: STREET 1: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212)421-7850 MAIL ADDRESS: STREET 1: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-08-10 0000038074 FOREST LABORATORIES INC FRX 0001224337 SALANS LESTER B C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK NY 10022 1 0 0 0 Common Stock 2009-08-10 4 A 0 1000 0 A 20000 D Stock Options (Right to Buy) 26.245 2009-08-10 4 A 0 4000 0 A 2010-02-10 2019-08-09 Common Stock 4000 4000 D These shares of common stock are issued under the Company's 2007 Equity Incentive Plan and are subject to a risk of forfeiture, which lapses as to 25% of the shares on the six month anniversary of the grant date (August 10, 2009) and as to 25% of the shares on each of the first three anniversaries of the grant date. This amount includes shares of common stock which are subject to a risk of forfeiture. /s/ Lester B. Salans 2009-08-10 -----END PRIVACY-ENHANCED MESSAGE-----